End-stage renal disease requiring dialysis is a commonly accepted condition in the life settlement market, and it generally increases the market value of a qualifying policy — but transplant candidacy can reduce or eliminate offers, which is the detail most families do not anticipate. That combination is what makes kidney failure different from most other conditions on these pages. Two people on the same dialysis schedule can be priced very differently depending on whether one is active on a transplant waiting list.
There is a second detail specific to kidney failure and worth checking first: Medicare eligibility. Federal law extends Medicare to individuals with end-stage renal disease regardless of age, subject to a coordination period during which an employer group health plan pays primary. That coverage can materially reduce the household’s out-of-pocket pressure, which sometimes removes the urgency behind a policy sale entirely.
Below is what underwriters read, how the alternatives rank, and when keeping or surrendering the policy is the honest answer. Pine Lake Life Solutions provides education and a free policy review, not medical, legal, or tax advice.
In This Article

Check Medicare and Coverage Before You Check the Market
Medicare eligibility for people with end-stage renal disease is established by federal statute and is not age-dependent. Coverage typically begins in a specified month after dialysis starts, with an earlier start possible for those completing a home dialysis training program or receiving a transplant. Where an employer group health plan is in place, a 30-month coordination period generally applies during which the group plan pays primary and Medicare pays secondary. Confirm the current rules and your own start date with Medicare or your dialysis center’s social worker, as of 2026.
Why this comes first: a large share of the financial pressure families feel after a kidney failure diagnosis is medical-bill pressure, and the reason people consider selling a policy is usually cash flow. If Medicare and a supplement resolve most of that, the argument for a sale weakens considerably. Dialysis centers employ social workers whose job includes exactly this kind of benefits coordination, and the service is free.
What Underwriters Read in a Renal File
The clinical anchors are dialysis modality — in-center hemodialysis, home hemodialysis, or peritoneal dialysis — along with time on dialysis, adequacy measures such as Kt/V, vascular access type and complication history, and interdialytic weight gain and fluid management. Missed or shortened treatments are a strong negative prognostic signal and appear plainly in dialysis center records.
The comorbidity picture usually dominates. Diabetes as the cause of renal failure, cardiovascular disease, heart failure, peripheral vascular disease, amputation history, recurrent access infections, and poor nutritional status all shorten estimates significantly. Serum albumin is a routinely tracked and highly predictive marker in this population. Age at initiation of dialysis matters as well.
Because dialysis patients are seen several times a week, the medical record in these cases is unusually dense and current. That works in the policyholder’s favor: underwriters can build a well-supported estimate rather than a conservative one built on thin documentation.
The Transplant Wrinkle
A successful kidney transplant substantially changes long-term prognosis, and buyers know it. An insured who is actively listed for transplant and considered a strong candidate presents the possibility of a much longer holding period than the dialysis record alone suggests, and offers reflect that uncertainty — sometimes by dropping sharply, sometimes by disappearing.
Conversely, an insured who has been evaluated and declined for transplant because of cardiac disease, frailty, or other contraindications generally receives a shorter estimate. None of this is a reason to alter medical decisions; a transplant is a health outcome, not a financial variable, and no one should factor an insurance offer into transplant listing. It is simply a reason to expect the underwriting question to be asked and answered directly. This is one specific case of the broader dynamic described in why improved health can lower an offer.
| Factor | Where It Appears | Typical Effect on Value |
|---|---|---|
| Years on dialysis | Dialysis center records | Longer duration generally raises value |
| Diabetes as underlying cause | Nephrology history | Raises value |
| Cardiovascular comorbidity | Cardiology records | Materially raises value |
| Serum albumin and nutrition | Routine dialysis labs | Low albumin raises value |
| Missed or shortened treatments | Treatment logs | Raises value |
| Active transplant listing | Transplant center evaluation | Lowers value or ends interest |
| Death benefit under $100,000 | Policy cover page | Usually no market interest |

The Policy Has to Qualify on Its Own
Health is one gate; the contract is the other. Death benefit of roughly $100,000 or more is the practical floor, since underwriting, escrow, and legal costs are largely fixed. Permanent products — universal life, guaranteed universal life, whole life, indexed universal life — transact routinely, as does term with an unexpired conversion right. Non-convertible term generally does not, because it will expire before it pays.
Outstanding policy loans reduce any offer dollar for dollar, and a policy inside its two-year contestability window is generally avoided. On universal life, request an in-force illustration and look at whether cost of insurance charges are escalating; a policy that will demand large premium increases to stay alive is worth less to a buyer than its face amount suggests. See why the in-force illustration matters.
Every Alternative Side by Side
Keep and keep paying. Correct when a spouse or dependent will need the benefit and the premium is affordable. Death proceeds are generally received income-tax-free by beneficiaries under Internal Revenue Code section 101(a)(1).
Chronic illness or accelerated death benefit rider. Check the rider schedule. Chronic illness riders typically require inability to perform two of six activities of daily living, or severe cognitive impairment, certified by a licensed health practitioner. Qualifying payments are generally excluded from income under Internal Revenue Code section 101(g), subject to statutory conditions and per-diem limits for chronically ill insureds.
Policy loan or withdrawal. Cash without giving up coverage; interest accrues and unpaid loans reduce the benefit.
Reduced paid-up insurance. Stops premiums, keeps a smaller fully paid death benefit. The cleanest answer when premium strain is the whole problem.
1035 exchange. Internal Revenue Code section 1035 permits a tax-free exchange into another life contract, an annuity, or a qualified long-term care contract. Rarely useful here, since it means giving up coverage underwritten when the insured was healthier.
Surrender. Pays cash surrender value only — usually the lowest-value exit for a policy the market would price higher.
Life settlement. A lump sum today, appropriate when coverage is no longer needed, transportation and care costs are mounting, or a spouse has left work to provide care.
When Selling Is Not the Right Move
Three clear cases. First, when the death benefit is the surviving spouse’s plan. Dialysis households frequently lose a second income to caregiving, and a lump sum at 10% to 35% of face value does not replace the full benefit for a survivor who will live many more years. Second, when the policy is small — under roughly $100,000 — where the market will not engage and the carrier is the only counterparty. Third, when Medicare, a supplement, and a dialysis center social worker can resolve the actual cash problem without touching the policy at all.
There is also a Medicaid consideration. If Medicaid is paying for care or is likely to, both the policy’s cash value and any sale proceeds are relevant. Proceeds become a countable resource, and spending them incorrectly can create eligibility problems. Read how life insurance counts toward Medicaid and coordinate with an elder law attorney before closing anything.
Ranges, Timeline, and Getting a Straight Answer
The U.S. Government Accountability Office’s market study (GAO-10-775) found sellers typically received roughly 10% to 35% of face value, several times what surrendering the same policies would have paid. Where a dialysis case lands depends on time on dialysis, comorbidities, transplant status, the death benefit, and the cost of holding the policy.
Expect roughly 60 to 120 days from first review to funded payment. You will sign a HIPAA authorization, which under 45 CFR 164.508 must state an expiration date and your right to revoke. Dialysis center records are usually easy to obtain, which can shorten the medical retrieval step. Funds should sit with an independent escrow agent until the carrier records the ownership change, and most states provide a rescission window after funding, commonly 15 to 30 days.
To find out where your policy stands, send the policy cover page showing insurer, policy number, face amount, and issue date. The review is free with no obligation, and you will get a straight answer even when that answer is to keep the policy. Call (305) 209-7183. This page is educational only and is not medical, legal, or tax advice.
Frequently Asked Questions
Can someone on dialysis sell a life insurance policy?
Yes, if the policy qualifies on size and type. End-stage renal disease is a well-documented condition that the secondary market accepts routinely, and dialysis records are unusually complete, which helps underwriting. The policy still needs roughly $100,000 or more of death benefit.
Does being on a transplant list affect the offer?
Yes, usually downward. Active candidacy for a kidney transplant raises the possibility of a much longer holding period for a buyer, which reduces what they can pay and sometimes ends interest entirely. Medical decisions about transplant should never be shaped by an insurance offer.
What records will underwriters ask for?
Typically nephrology notes, dialysis center treatment records and labs, cardiology records, and documentation of comorbidities such as diabetes or vascular disease. Adequacy measures, serum albumin, access history, and missed treatments are all commonly reviewed. A HIPAA authorization is required before any records are obtained.
Does Medicare cover me even though I am under 65?
Federal law extends Medicare to individuals with end-stage renal disease regardless of age, with a defined start month and a coordination period when an employer group health plan is involved. Confirm your specific dates with Medicare or your dialysis center’s social worker before making financial decisions.
How much might the policy be worth?
The federal GAO study (GAO-10-775) found sellers typically received roughly 10% to 35% of face value, often several times surrender value. Actual pricing depends on comorbidities, transplant status, the death benefit, and the ongoing cost of keeping the policy in force.
Will a settlement affect Medicaid?
It can. Sale proceeds become a countable resource for needs-based programs, and how they are spent or sheltered matters. If Medicaid is paying for any part of care, coordinate with an elder law attorney before closing so eligibility is not disrupted.
How long does the process take?
Roughly 60 to 120 days from initial review to funded payment. Because dialysis records are generated several times a week and are easy to obtain, medical retrieval is often quicker than in other cases. Most states then provide a rescission window, commonly 15 to 30 days after funding.
Find out what your policy is worth — free, confidential, no obligation.
A 15-minute educational review covers your eligibility, every alternative, and a realistic view of what each path would net you.
Related Reading
- Chronic Illness Life Settlement
- What Is An In Force Illustration
- Life Insurance Counts Medicaid Asset
- Improved Health Lower Offer
- What Is Life Expectancy Underwriting
- Health Requirements For A Life Settlement
- Minimum Policy Size For A Life Settlement
- Sell Policy Pay Medical Bills
Pine Lake Life Solutions does not purchase life insurance policies and does not provide legal, tax, or investment advice. Information provided is for educational purposes only. Eligibility for any option, including life settlements, is not guaranteed and depends on individual circumstances, policy terms, underwriting, and market conditions. Consult independent legal, tax, or financial professionals before making decisions regarding a life insurance policy.